By Finance Pulse in LLY —

Eli Lilly's Market Cap Soars $170B with Zepbound Demand

Eli Lilly's market cap surged by $170 billion as demand for its obesity drug, Zepbound, positions it as a leader in the obesity drug market. Discover the impact.

A visually striking illustration of a rising stock graph with Eli Lilly's logo, set against a backdrop of vibrant colors symbolizing growth and innovation.
Eli Lilly's Market Cap Soars $170B with Zepbound Demand

Eli Lilly saw a significant increase in market cap due to high demand for its Zepbound drug.

Source